Andrade, Cashman et al. evaluate varying immunization regimens of INO-4500, a DNA-based vaccine for Lassa fever, in non-human primates. INO-4500 induces humoral and cellular immune responses, conferring short- and long-term protection from lethal Lassa Virus challenge.
- Viviane M. Andrade
- Kathleen Cashman
- Trevor R. F. Smith
